S. No. |
Topic Covered in Lecture |
Lecture + MCQ + Discussion Web Link |
Notes link |
|
|
1 |
Introduction of Pharmacovigilance What is Pharmacovigilance? Purpose & Activity |
https://youtu.be/86-MT1m_rT0 |
https://drive.google.com/file/d/1i-syO2XjEte9116nczdKnc8Mmw0jcfrh/view?usp=share_link
|
2 |
History of Pharmacovigilance ; Development of Pharmacovigilance
MCQ |
https://youtu.be/T_5BJ1rL4uw
|
https://drive.google.com/file/d/1ot3Cu4hX6HBi9vuevkfBLCmTgKUJQqy4/view?usp=share_link
|
3 |
Pharmacovigilance Programme of India; PVPI Mission, |
https://youtu.be/GlF7tZrjLeg |
https://drive.google.com/file/d/1UYY88moxGAiHVDK5mhOW_pN9xmSHgQZx/view?usp=share_link
|
|
History ; Objective of PVPI; MCQ on PVPI |
https://youtu.be/T_5BJ1rL4uw |
https://drive.google.com/file/d/1ot3Cu4hX6HBi9vuevkfBLCmTgKUJQqy4/view?usp=share_link
|
|
Importance of safety monitoring of Medicine |
|
https://globalresearchonline.net/journalcontents/v70-1/02.pdf
|
4 |
WHO international drug monitoring Programme |
https://youtu.be/QedflWbRWdc |
https://drive.google.com/file/d/1oZkfDt-1ScwkkVzoOjrnZqLgL6Xxixd0/view?usp=share_link
|
5 |
Definitions and classification of ADR |
https://youtu.be/SzEYY33RcZI |
https://drive.google.com/file/d/1nEEWMCMux_2weJt8aS7_dzT4Bv28OqDi/view?usp=share_link
|
6 |
Classification of Adverse Drug Reaction | Mnemonic | TYPE of ADR | MCQ on ADR |
https://youtu.be/V1LGAEO83BU |
https://drive.google.com/file/d/1nEEWMCMux_2weJt8aS7_dzT4Bv28OqDi/view?usp=share_link
https://drive.google.com/file/d/1vELZExESWdIAIjT3I5ljoEbmjwrjN-k6/view?usp=share_link
|
7 |
Detection of ADR; MCQ |
https://youtu.be/C6cPFl4IIS8 |
https://drive.google.com/file/d/1Ix1Keog80O3qfHhcsu6eSO-cpcMD_hEx/view?usp=share_link
|
8 |
REPORTING OF ADVERSE DRUG REACTION | What, where, how and whom to report ADR ? PHARMACOVIGILANCE MCQ |
https://youtu.be/LbOu86w3EPw |
https://drive.google.com/file/d/1KrR1XI9G_s5e11x7mSxt97Y3Kq_YzmNa/view?usp=share_link
|
9 |
Severity and Seriousness of ADR | Hartwig Scale | MCQ on ADR | Classification of ADR Severity |
https://youtu.be/WUq64s0dNq4 |
https://drive.google.com/file/d/1MMHOJhRMnPeZYxRdYVgoVwFCBvmGBK9a/view?usp=share_link
|
10 |
Casualty Assessment Method | Naranjo Scale | Casualty Grading | Algorithm |
https://youtu.be/sTPLPH4EigA |
https://drive.google.com/file/d/1E-jim0XbI_2P6ftdPQgN54BYQ_hL2gKM/view?usp=share_link
|
11 |
Management of adverse drug reactions; MCQ |
https://youtu.be/ssyuqLf-qW4 |
https://drive.google.com/file/d/1WcEwxCCUOmI75ZBTbNi0Qqu0jHt8Uliu/view?usp=share_link
|
12 |
Naranjo Scale |
https://youtu.be/ayeywcC3ca0 |
|
13 |
Terminologies of adverse medication related events; Regulatory terminologies; WHO drug dictionary |
https://youtu.be/2Y2UGvXuDjo |
https://drive.google.com/file/d/1vwfqUWMnjJOYZL5dwuYEY14-blCESZQL/view?usp=share_link
|
14 |
Anatomical, Therapeutic and Chemical Classification of Drug | ATC classification |
https://youtu.be/TVYkp9jWBEM |
https://drive.google.com/file/d/1PMcOQssV2qpuDp54f_1fe_kUq3r-kk71/view?usp=share_link
|
15 |
International classification of diseases | |
https://youtu.be/LesA4hf1H4Y |
https://drive.google.com/file/d/1x0d0NKFsyIci7pq50B8_3v4Urn8WqyoA/view?usp=share_link
|
16 |
Daily defined doses |
https://youtu.be/y2cloulWU1Q |
https://drive.google.com/file/d/1LfOlr049bRISJNawB7K7b8W7Ouw-iYEL/view?usp=share_link
|
17 |
International Non proprietary Names for drugs |
https://youtu.be/Dfrj9Iv5nIg |
https://drive.google.com/file/d/1xXfes8wd4AGm0TBdY5abROEkEf-NUI6Z/view?usp=share_link
|
18 |
WHO adverse reaction terminologies; Basic drug information resources ; Specialized resources for A |
https://youtu.be/CjmL8uqf42k |
https://drive.google.com/file/d/1vwfqUWMnjJOYZL5dwuYEY14-blCESZQL/view?usp=share_link
|
19 |
MedDRA and Standardized MedDRA queries |
https://youtu.be/NxrvRheKpS8 |
https://drive.google.com/file/d/1yT0_mUH_0Dn0Jrdpx4oEhJfYr2vGyEJ_/view?usp=share_link
|
20 |
Establishing in a hospital |
https://youtu.be/Ua5zc0dTk00 |
https://drive.google.com/file/d/17NeyqZwfmRFxpQW8qs7wluQonmEjPoy6/view?usp=share_link
|
21 |
Establishing a national Programme |
https://youtu.be/3oG8nwupZ4g |
https://drive.google.com/file/d/1NxtFiR-ruF1K1QLURd6NSXNJbgOgYs8T/view?usp=share_link
|
22 |
Contract Research Organizations (CROs) |
https://youtu.be/JLOBp_K2ZV0 |
https://drive.google.com/file/d/1jOUPgSvWuzPd3b61Io7HxS_gH-gV_p8t/view?usp=share_link
|
23 |
Vaccine Pharmacovigilance |
https://youtu.be/HTJElrNyEbk |
https://drive.google.com/file/d/1iL5shpIsGF0kmixqCedfc7IRiR6_88ww/view?usp=share_link
|
24 |
Vaccination failure |
https://youtu.be/2gLzlTAtwm8 |
https://drive.google.com/file/d/1iL5shpIsGF0kmixqCedfc7IRiR6_88ww/view?usp=share_link
|
25 |
Adverse events following immunization |
https://youtu.be/W8iRw74Yzlc |
https://drive.google.com/file/d/1Djjc7F94VCIWL_33MY1nAtG8GZpuasw7/view?usp=share_link
https://drive.google.com/file/d/1T2k-IMgMX4J15tBmEzFX3_E7fShUdPwa/view?usp=share_link
|
26 |
Pharmacovigilance Methods | Classification of Pharmacovigilance Methods |
https://youtu.be/h56GU7FLYEI |
https://drive.google.com/file/d/1yfzUhAzJ4VZ5r5kEPd4kgcxHoUmS-696/view?usp=share_link
|
27 |
Passive Surveillance | Spontaneous reports and case series |
https://youtu.be/8gg8Fufidmk |
https://drive.google.com/file/d/18AmyqJ9RPH5AfxQQOkK_uNTQNecDKYiX/view?usp=share_link
|
28 |
Active surveillance | Sentinel Sites | Drug Event Monitoring | Registries | Cohort Study |
https://youtu.be/-8rFw0MpbJA |
https://drive.google.com/file/d/1Ir8tYfDGaAp2R1BFqavR1r4w9l3p3Ukw/view?usp=share_link
|
29 |
Comparative observational studies – Cross sectional study |
https://youtu.be/urX1ejgtYgA |
https://drive.google.com/file/d/1mG0k4em4l0kTV1M1FD0ixp8h9P9DBeXP/view?usp=share_link
|
30 |
Case Control Study |
https://youtu.be/YkzE7uzEZhg |
https://drive.google.com/file/d/14Dq8Tdwz14n25WLKTwz6o9TV5j40JHMY/view?usp=share_link
|
31 |
Cross Sectional Study | Pros & Cons of Cross Sectional |
https://youtu.be/9r3rl_RnFoo |
https://drive.google.com/file/d/1ExkVgLQ6ElibINXsEssEMmotk08W1wSR/view?usp=share_link
|
32 |
Targeted Clinical Investigation |
https://youtu.be/xB2PQSq-8qI |
https://drive.google.com/file/d/1hLjwSeO4wk0Am-gIzfvHvDAJK_tlN5yt/view?usp=share_link
|
33 |
Effective communication in Pharmacovigilance |
https://youtu.be/4LzZsUj_sN8 |
https://drive.google.com/file/d/11eMPyTTc6rTW1JM70tGD54Esan7sLQnX/view?usp=share_link
|
34 |
Communication in Drug Safety Crisis management |
https://youtu.be/EVkgkCNG5VE |
https://drive.google.com/file/d/14Dq8Tdwz14n25WLKTwz6o9TV5j40JHMY/view?usp=share_link
|
35 |
Communicating with Regulatory Agencies, Business Partners, Healthcare facilities & Media |
https://youtu.be/_asH_s6431o |
https://drive.google.com/file/d/13R_dzqL7bD2csQaODSrunaDEHjZlukVW/view?usp=share_link
|
36 |
Safety data generation; Pre clinical phase |
https://youtu.be/sbm0ppPZCyk |
https://drive.google.com/file/d/1HmXXDaeG7lTM_i8OvsTBgo9-FSJlBXl1/view?usp=share_link
|
37 |
Clinical Trial Introduction | Phases of Clinical Trial; Post approval phase (PMS) |
https://youtu.be/UHGs411rMmw |
https://drive.google.com/file/d/1bXfkEZe3ktBIeMgtWnAE2lDqqp-d69g2/view?usp=share_link
|
38 |
Organization and objectives of ICH- part 1 |
https://youtu.be/WX-cUwtwcXg |
https://drive.google.com/file/d/1WMdnMGn1kO0BFfzj_VU2–NYtxfMkj64/view?usp=share_link
|
39 |
Organization and objectives of ICH | Series & Codes- Part 2 |
https://youtu.be/X12sxXr1un8 |
https://drive.google.com/file/d/1WMdnMGn1kO0BFfzj_VU2–NYtxfMkj64/view?usp=share_link
|
40 |
Expedited reporting & Post approval expedited reporting |
https://youtu.be/5HFoX_QtEeo |
https://drive.google.com/file/d/1zkqqrdUzx1WlcnQnUCRJQ_6IDAFEg50c/view?usp=share_link
|
41 |
Individual case safety reports- part 1 |
https://youtu.be/Lo-6BFanx8Y |
https://drive.google.com/file/d/1CiCPamSF4Q_OZIDT6JgbdSxPJe_R9lAO/view?usp=share_link
|
42 |
ICH ICSR E2B R3 Guideline | How to Fill ICSR | What Data Needed in Individual case safety reports- part 2 |
https://youtu.be/wH1X71Hc2hE |
https://drive.google.com/file/d/1CiCPamSF4Q_OZIDT6JgbdSxPJe_R9lAO/view?usp=share_link
|
43 |
Periodic safety update reports- Part 1 |
https://youtu.be/lSkpAGP1TSU |
https://drive.google.com/file/d/1wuWJJEaR2zFBY-OCdZcOKsOCxtBWNkrb/view?usp=share_link
|
44 |
Periodic safety update reports- Part 2 |
https://youtu.be/c8gEgCz2G9o |
https://drive.google.com/file/d/1wuWJJEaR2zFBY-OCdZcOKsOCxtBWNkrb/view?usp=share_link
|
45 |
Pharmacogenomics of adverse drug reactions; Genetics related ADR with example focusing PK parameters. |
https://youtu.be/uTxuygxnuWc |
https://drive.google.com/file/d/1T5c4GcKuJik5FRcD6a6vYQ9xH4J5wStH/view?usp=share_link
|
46 |
Drug safety evaluation in special population- Paediatrics- Part 1 |
https://youtu.be/Nhs9v3a2CFA |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345950/
|
47 |
Drug safety evaluation in special population- Paediatrics- Part-2 |
https://youtu.be/jBFp_EaHpUk |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345950/
|
48 |
Drug safety evaluation in Pregnancy and lactation |
https://youtu.be/TvL7Vr7CRpU |
https://drive.google.com/file/d/17ud6Ak9gcwSQ_7ZMS-ixsBiEML54b6gq/view?usp=share_link
|
49 |
Drug safety evaluation in Geriatrics |
https://youtu.be/EXBfqKTWN3I |
https://drive.google.com/file/d/15BvF9NCY_Ad-L-wqD-6ybCVe3GqAb1xJ/view?usp=share_link
|
50 |
CIOMS Working Group |
https://youtu.be/nDA1AnILdHA |
https://drive.google.com/file/d/1gwzItIfSgw1on9-CohLMAKGiMdEm89Oo/view?usp=share_link
|
51 |
CIOMS Forms |
https://youtu.be/oODTxRYGDpo |
https://drive.google.com/file/d/1nAp1syBZlOOq1idTxXrL_K867geIsL-T/view?usp=share_link
|
52 |
CDSCO (India) and Pharmacovigilance |
https://youtu.be/Hd_4CaOzfbI |
https://drive.google.com/file/d/1kFZL9IPnXPWw5X9OSJf5dRojuY-e5aW3/view?usp=share_link
|
53 |
D&C Act and Schedule Y |
https://youtu.be/C8A70Qd2I7I |
https://rajswasthya.nic.in/Drug%20Website%2021.01.11/12%20D%20&%20C%20Act%20amended%20upto%2026%20of%2008.pdf
|
54 |
Differences in Indian and global pharmacovigilance requirements |
https://youtu.be/8Ai_fq3XCPk |
https://drive.google.com/file/d/1AQP8kOJGxp5p8y3Ss1GDv4uDoiDNk6lF/view?usp=share_link
|
55 |
MCQ on Clinical Trials | Clinical Trials Question Answer |
https://youtu.be/7NNUMrdgQ9o |
|
56 |
MCQ of Communication in Drug Safety Crisis management |
https://youtu.be/MUIGlvHJm44 |
|
57 |
MCQ on Effective communication in Pharmacovigilance |
https://youtu.be/6t0mzJ480BU |
|
58 |
MCQ on Communicating with Regulatory Agencies, Business Partners, Healthcare facilities & Media |
https://youtu.be/yBDu8DDZs2c |
|
59 |
MCQ Case Control Study with Answer |
https://youtu.be/G6OHfXuNmFc |
|
60 |
MCQ of Cross Sectional Study with Answer |
https://youtu.be/SYeQgxZVjM8 |
|
61 |
MCQ TARGETED CLINICAL ANSWER |
https://youtu.be/-cQXyulxZ3E |
|
62 |
MCQ with Answer on ICH Guidelines for Pharmacovigilance | Part -1 |
https://youtu.be/U08epUnyfa4 |
|
63 |
ICH Guidelines for Pharmacovigilance | Part -2 | |
https://youtu.be/X12sxXr1un8 |
|
64 |
|
https://youtu.be/M2o1M4GB9Sg |
https://rgcb.res.in/documents/Schedule-Y.pdf
|
65 |
|
https://youtu.be/sDrovcpUn_4 |
https://drive.google.com/file/d/12Nwf0n8OUCpWCPzA3MISCaFIuwYR17mj/view?usp=sharing
|
66 |
Eudravigilance
|
|
https://drive.google.com/file/d/1BtEWA8T66N_KFlIEGrJKvMRVf_PECLah/view?usp=share_link
|